Journal of Pediatrics Review

Published by: Kowsar

The Role of Urinary Biomarker Levels in Assessing the Presence and Severity of Ureteropelvic Junction Obstruction in Children: A Systematic Review and Meta-Analysis

Abbas Alipour 1 , Hamid Mohammadjafari 2 , * , Alireza Rafiei 3 and Omolbanin Amjadi 3
Authors Information
1 Thalassemia Research Center, Mazandaran University of Medical Sciences, Sari, IR Iran
2 Infectious Disease Research Center with Focus on Nosocomial Infection, Mazandaran University of Medical Sciences, Sari, IR Iran
3 Molecular and Cell Biology Research Center, Department of Immunology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, IR Iran
Article information
  • Journal of Pediatrics Review: July 2016, 4 (2); e7567
  • Published Online: July 27, 2016
  • Article Type: Review Article
  • Received: June 15, 2016
  • Revised: July 5, 2016
  • Accepted: July 12, 2016
  • DOI: 10.17795/jpr-7567

To Cite: Alipour A, Mohammadjafari H, Rafiei A, Amjadi O. The Role of Urinary Biomarker Levels in Assessing the Presence and Severity of Ureteropelvic Junction Obstruction in Children: A Systematic Review and Meta-Analysis, J Pediatr Rev. 2016 ;4(2):e7567. doi: 10.17795/jpr-7567.

Abstract
Copyright: Copyright © 2016, Journal of Pediatrics Review. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Objectives
3. Data Sources
4. Study Selection
5. Data Extraction
6. Results
7. Discussion
8. Conclusion
References
  • 1. Alberti C. Congenital ureteropelvic junction obstruction: physiopathology, decoupling of tout court pelvic dilatation-obstruction semantic connection, biomarkers to predict renal damage evolution. Eur Rev Med Pharmacol Sci. 2012; 16(2): 213-9[PubMed]
  • 2. Mohammadjafari H, Alam A, Kosarian M, Mousavi SA, Kosarian S. Vesicoureteral reflux in neonates with hydronephrosis; role of imaging tools. Iran J Pediatr. 2009; 19(4): 347-53
  • 3. Decramer S, Bascands JL, Schanstra JP. Non-invasive markers of ureteropelvic junction obstruction. World J Urol. 2007; 25(5): 457-65[DOI][PubMed]
  • 4. Abedi SM, Mohammadjafari H, Hosseinimehr SJ, Mardanshahi A, Shahhosseini R. Imaging of renal cortex in nuclear medicine. J Clin E. 2014; 2(1): 50-69
  • 5. Orton D. Towards Biomarker Discovery In Congenital Urinary Tract Obstruction. J Dalhousie Univ. 2014;
  • 6. Lucarelli G, Mancini V, Galleggiante V, Rutigliano M, Vavallo A, Battaglia M, et al. Emerging urinary markers of renal injury in obstructive nephropathy. Biomed Res Int. 2014; 2014: 303298[DOI][PubMed]
  • 7. Shokeir AA. Role of urinary biomarkers in the diagnosis of congenital upper urinary tract obstruction. Indian J Urol. 2008; 24(3): 313-9[DOI][PubMed]
  • 8. Manucha W. Biochemical-molecular markers in unilateral ureteral obstruction. Biocell. 2007; 31(1): 1-12[PubMed]
  • 9. Zieg J, Blahova K, Seeman T, Bronsky J, Dvorakova H, Pechova M, et al. Urinary transforming growth factor-beta1 in children with obstructive uropathy. Nephrology (Carlton). 2011; 16(6): 595-8[DOI][PubMed]
  • 10. Vasconcelos MA, Bouzada MC, Silveira KD, Moura LR, Santos FF, Oliveira JM, et al. Urinary levels of TGF beta-1 and of cytokines in patients with prenatally detected nephrouropathies. Pediatr Nephrol. 2011; 26(5): 739-47[DOI][PubMed]
  • 11. Sager C, Lopez JC, Duran V, Burek C, Perazzo E. Transforming growth factor-beta1 in congenital ureteropelvic junction obstruction: diagnosis and follow-up. Int Braz J Urol. 2009; 35(3): 315-23[PubMed]
  • 12. Palmer LS, Maizels M, Kaplan WE, Firlit CF, Cheng EY. Urine levels of transforming growth factor-beta 1 in children with ureteropelvic junction obstruction. Urology. 1997; 50(5): 769-73[DOI][PubMed]
  • 13. Gawlowska-Marciniak A, Niedzielski JK. Evaluation of TGF-beta1, CCL5/RANTES and sFas/Apo-1 urine concentration in children with ureteropelvic junction obstruction. Arch Med Sci. 2013; 9(5): 888-94[DOI][PubMed]
  • 14. Taha MA, Shokeir AA, Osman HG, Abd El-Aziz Ael A, Farahat SE. Pelvi-ureteric junction obstruction in children: the role of urinary transforming growth factor-beta and epidermal growth factor. BJU Int. 2007; 99(4): 899-903[DOI][PubMed]
  • 15. El-Sherbiny MT, Mousa OM, Shokeir AA, Ghoneim MA. Role of urinary transforming growth factor-beta1 concentration in the diagnosis of upper urinary tract obstruction in children. J Urol. 2002; 168(4 Pt 2): 1798-800[DOI][PubMed]
  • 16. Furness P3, Maizels M, Han SW, Cohn RA, Cheng EY. Elevated bladder urine concentration of transforming growth factor-beta1 correlates with upper urinary tract obstruction in children. J Urol. 1999; 162(3 Pt 2): 1033-6[PubMed]
  • 17. Liatsikos EN, Dinlenc CZ, Bernardo NO, Kapoor R, Jabbour ME, Smith AD, et al. Endopyelotomy failure is associated with reduced urinary transforming growth factor-beta1 levels in patients with upper urinary tract obstruction. J Endourol. 2001; 15(6): 567-70[DOI][PubMed]
  • 18. Li ZZ, Zhao ZZ, Wen JG, Xing L, Zhang H, Zhang Y. Early alteration of urinary exosomal aquaporin 1 and transforming growth factor beta1 after release of unilateral pelviureteral junction obstruction. J Pediatr Surg. 2012; 47(8): 1581-6[DOI][PubMed]
  • 19. Skalova S, Rejtar P, Kutilek S. Increased urinary N-acetyl-beta-D-glucosaminidase activity in children with hydronephrosis. Int Braz J Urol. 2007; 33(1): 80-3[PubMed]
  • 20. Taha MA, Shokeir AA, Osman HG, Abd El-Aziz Ael A, Farahat SE. Obstructed versus dilated nonobstructed kidneys in children with congenital ureteropelvic junction narrowing: role of urinary tubular enzymes. J Urol. 2007; 178(2): 640-6[DOI][PubMed]
  • 21. Rathod KJ, Samujh R, Agarwal S, Kanojia RP, Sharma U, Prasad R. Hydronephrosis due to pelviureteric junction narrowing: Utility of urinary enzymes to predict the need for surgical management and follow-up. J Indian Assoc Pediatr Surg. 2012; 17(1): 1-5[DOI][PubMed]
  • 22. Mohammadjafari H, Rafiei A, Mousavi SA, Alaee A, Yeganeh Y. Role of urinary levels of endothelin-1, monocyte chemotactic peptide-1, and N-acetyl glucosaminidase in predicting the severity of obstruction in hydronephrotic neonates. Korean J Urol. 2014; 55(10): 670-6[DOI][PubMed]
  • 23. Wasilewska A, Taranta-Janusz K, Debek W, Zoch-Zwierz W, Kuroczycka-Saniutycz E. KIM-1 and NGAL: new markers of obstructive nephropathy. Pediatr Nephrol. 2011; 26(4): 579-86[DOI][PubMed]
  • 24. Cost NG, Noh PH, Devarajan P, Ivancic V, Reddy PP, Minevich E, et al. Urinary NGAL levels correlate with differential renal function in patients with ureteropelvic junction obstruction undergoing pyeloplasty. J Urol. 2013; 190(4 Suppl): 1462-7[DOI][PubMed]
  • 25. Madsen MG, Norregaard R, Palmfeldt J, Olsen LH, Frokiaer J, Jorgensen TM. Urinary NGAL, cystatin C, beta2-microglobulin, and osteopontin significance in hydronephrotic children. Pediatr Nephrol. 2012; 27(11): 2099-106[DOI][PubMed]
  • 26. Xie Y, Xue W, Shao X, Che X, Xu W, Ni Z, et al. Analysis of a urinary biomarker panel for obstructive nephropathy and clinical outcomes. PLoS One. 2014; 9(11): 112865[DOI][PubMed]
  • 27. Madsen MG, Norregaard R, Palmfeldt J, Olsen LH, Frokiaer J, Jorgensen TM. Epidermal growth factor and monocyte chemotactic peptide-1: potential biomarkers of urinary tract obstruction in children with hydronephrosis. J Pediatr Urol. 2013; 9(6 Pt A): 838-45[DOI][PubMed]
  • 28. Mohammadjafari H, Rafiei A, Kosaryan M, Yeganeh Y, Hosseinimehr SJ. Determination of the severity of ureteropelvic junction obstruction using urinary epidermal growth factor and kidney injury molecule 1 levels. Biomark Med. 2014; 8(10): 1199-206[DOI][PubMed]
  • 29. Taranta-Janusz K, Wasilewska A, Debek W, Waszkiewicz-Stojda M. Urinary cytokine profiles in unilateral congenital hydronephrosis. Pediatr Nephrol. 2012; 27(11): 2107-13[DOI][PubMed]
  • 30. Taha MA, Shokeir AA, Osman HG, Abd el-Aziz Ael A, Farahat SE. Diagnosis of ureteropelvic junction obstruction in children: role of endothelin-1 in voided urine. Urology. 2007; 69(3): 560-4[DOI][PubMed]
  • 31. Kajbafzadeh AM, Elmi A, Talab SS, Emami H, Esfahani SA, Saeedi P. Urinary and serum carbohydrate antigen 19-9 as a biomarker in ureteropelvic junction obstruction in children. J Urol. 2010; 183(6): 2353-60[DOI][PubMed]
  • 32. Tian F, Gu C, Zhao Z, Li L, Lu S, Li Z. Urinary Emmprin, matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 as potential biomarkers in children with ureteropelvic junction narrowing on conservative treatment. Nephrology (Carlton). 2015; 20(3): 194-200[DOI][PubMed]
  • 33. Jianguo W, Zhenzhen L, Xianghua L, Zhanzheng Z, Suke S, Suyun W. Serum and urinary procollagen III aminoterminal propeptide as a biomarker of obstructive nephropathy in children. Clin Chim Acta. 2014; 434: 29-33[DOI][PubMed]
  • 34. Li Z, Liu X, Liu S, Gu C, Tian F, Wen J. Urinary heme oxygenase-1 in children with congenital hydronephrosis due to ureteropelvic junction obstruction. Biomarkers. 2012; 17(5): 471-6[DOI][PubMed]
  • 35. Taranta-Janusz K, Wasilewska A, Debek W, Filonowicz R, Michaluk-Skutnik J. Urinary angiotensinogen as a novel marker of obstructive nephropathy in children. Acta Paediatr. 2013; 102(9): 429-33[DOI][PubMed]
  • 36. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005; 5: 13[DOI][PubMed]
  • 37. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003; 3: 25[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader